US Congress House Bill 5239 (Prior Session Legislation)

---

Spectrum: Partisan Bill (Republican 2-0)
Status: Introduced on November 21 2019 - 25% progression, died in committee
Action: 2019-11-22 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Introduced) [PDF]

Requires that all prescription drug manufacturers submit certain information for every drug marketed in the United States to the Department of Health and Human Services (HHS). Specifically, manufacturers must provide information about cost, pricing, and rebates. Manufacturers are also required to submit any price changes to a prescription drug at least 30 days in advance.HHS must make this information available through a public database that enables consumers to subscribe to price change notifications for different types of prescriptions drugs.

Prescription Drug Price Reporting Act

Rep. David Joyce [R-OH]

Rep. Anthony Gonzalez [R-OH]

Date	Chamber	Action
2019-11-22	House	Referred to the Subcommittee on Health.
2019-11-21	House	Referred to the House Committee on Energy and Commerce.
2019-11-21	House	Introduced in House

SB1664 (Related) 2019-05-23 - Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

Type	Source
Summary	https://www.congress.gov/bill/116th-congress/house-bill/5239/all-info
Text	https://www.congress.gov/116/bills/hr5239/BILLS-116hr5239ih.pdf